Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

353.23 +3.58 (+1.02%)
Streaming Delayed Price Updated: 10:11 AM EDT, Sep 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 72,550
Open 351.14
Bid (Size) 352.98 (1)
Ask (Size) 353.40 (2)
Prev. Close 349.65
Today's Range 350.77 - 353.50
52wk Range 278.19 - 367.00
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Crispr Therapeutics, And CRISPR Gene-Editing, Face Their Make-Or-Break Moment
The FDA is within three months of making a decision on the first-ever CRISPR-based drug. 
Via Investor's Business Daily
Exposures Product Safety
Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher
These pharma stocks could boom in the coming years, riding their diversified pipelines with massive addressable markets higher. 
Via InvestorPlace

Performance

YTD
+23.50%
+23.50%
1 Month
+0.46%
+0.46%
3 Month
+0.70%
+0.70%
6 Month
+12.41%
+12.41%
1 Year
+24.05%
+24.05%

More News

Read More
Three Of Our Top Picks For Your Healthcare Portfolio
Via Talk Markets
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher
Via InvestorPlace
This Is What Whales Are Betting On Vertex Pharmaceuticals
Via Benzinga
Price Over Earnings Overview: Vertex Pharmaceuticals
Via Benzinga
2 Healthcare Stocks That Could Make You Richer
Via The Motley Fool
Is NASDAQ:VRTX suited for quality investing?
Via Chartmill
Buying These 2 Remarkable Growth Stocks in Any Market Could Be a Genius Move
Via The Motley Fool
3 Magnificent Growth Stocks to Buy Right Now
Via The Motley Fool
Meta Stock Leads 5 Names Showing Resilience In Market Downturn
Via Investor's Business Daily
3 Unstoppable Stocks to Buy and Hold for the Next 20 Years
Via The Motley Fool
Where Will CRISPR Therapeutics Be in 5 Years?
Via The Motley Fool
2 Top Trends to Invest $500 In Right Now
Via The Motley Fool
Here's the 1 Cathie Wood Stock Most Likely to Turn $100,000 Into $1 Million Over the Next 20 Years
Via The Motley Fool
Looking for Growth? These Companies' Revenue May Skyrocket
Via The Motley Fool
If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today
Via The Motley Fool
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
Via Benzinga
Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor for Children With Cystic Fibrosis Ages 2 Through 5
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
Via Investor's Business Daily
Exposures Product Safety
3 Top Healthcare Stocks Defying the Bear Market
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Vertex Researchers Awarded 2024 Breakthrough Prize in Life Sciences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Better Bull Market Buy: CRISPR vs. Medtronic Stock
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.